102 results

• Ozempic “Science Day” Presentations Will Provide Court An Overview of Medical Issues Linked To GLP1 Medications

  August 16, 2024

  Irvin Jackson

  Originally set for June, before the presiding judge passed away, a new Ozempic "Science Day" has been scheduled before the new judge overseeing the litigation, to educate the court on the science behind claims of gastroparesis.

• Trulicity Lawsuit Alleges Intestinal Obstruction Caused By Side Effects of Diabetes Drug

  August 12, 2024

  Irvin Jackson

  A Trulicity lawsuit seeks damages for a Pennsylvania man who suffered severe ileus, intestinal obstruction, nausea and other adverse side effects from the diabetes drug.

• Wegovy and Similar Weight-Loss Drugs May Increase Risk of Eating Disorders, Doctors Tell NBC News

  August 8, 2024

  Irvin Jackson

  Medical experts are warning that there needs to be more research into the effects of weight loss drugs like Wegovy and Zepbound on eating disorders, such as anorexia, which may be exacerbated in patients taking the medications.

• FDA Database Reveals High Number of Severe Adverse Events Involving Problem from Ozempic, Similar GLP1 Drugs

  August 5, 2024

  Irvin Jackson

  A new study finds significant serious adverse events linked to the use of diabetes and weight loss drugs like Ozempic and Wegovy, with older drugs in the class linked to a higher risk of death.

• Three Years of Ozempic Use Led to Gastroparesis Diagnosis, Lawsuit Alleges

  August 1, 2024

  Irvin Jackson

  A Florida man has filed an Ozempic lawsuit against Novo Nordisk, adding to mounting claims that Novo Nordisk failed to warn doctors and patients about the risks of gastroparesis.

• Emergency Rooms Should Be Ready to Handle Ozempic, Mounjaro Side Effects, Doctor Warns

  July 29, 2024

  Irvin Jackson

  A doctor is warning Emergency Rooms to prepare for patients suffering from Ozempic, Mounjaro side effects and the side effects of similar drugs, which may cause stomach paralysis and an increased risk of suffocation during sedation.

• Lawsuit Alleges Novo Nordisk Downplayed Ozempic Gastroparesis Risks

  July 24, 2024

  Irvin Jackson

  An Ozempic gastroparesis lawsuit claims Novo Nordisk purposefully failed to warn patients and the medical community that symptoms such as nausea, vomiting and diarrhea could be signs of serious gastrointestinal complications.

• Judge Allows New Ozempic, Wegovy Lawsuits To Be Directly Filed in Federal MDL

  July 16, 2024

  Irvin Jackson

  A federal judge is allowing those presenting Ozempic, Wegovy and Mounjaro lawsuits to file them directly with the MDL court to speed up the process of preparing the cases for potential future bellwether trials.

• Study Finds Mounjaro and Zepbound More Effective Weight Loss Treatments Than Ozempic, Wegovy

  July 12, 2024

  Irvin Jackson

  A new study finding that Mounjaro may cause more weight loss than Ozempic, also determined they were both linked to increased risks of gastrointestinal side effects.

• Novo Nordisk Fails To Warn About Risk of Gastroparesis from Wegovy, Lawsuit Alleges

  July 3, 2024

  Irvin Jackson

  A Wegovy gastroparesis lawsuit filed by a Pennsylvania couple accuses the manufacturer, Novo Nordisk, of failing to provide adequate warnings about the true risks of the injectable weight loss drug.